Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
InSightec
IRCCS Ospedale San Raffaele
Mayo Clinic
Nationwide Children's Hospital
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Beijing Tiantan Hospital
University Health Network, Toronto
The Children's Hospital of Zhejiang University School of Medicine
M.D. Anderson Cancer Center
University College Cork
Blokhin's Russian Cancer Research Center
M.D. Anderson Cancer Center
Tata Memorial Centre
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
University of Birmingham
Virginia Commonwealth University
Telix Pharmaceuticals (Innovations) Pty Limited
Medical University of Warsaw
Mayo Clinic
Washington University School of Medicine
Tianjin Medical University
Maastricht Radiation Oncology
Leica Microsystems (Schweiz) AG
Istituto Oncologico Veneto IRCCS